Suppression of migratory/invasive ability and induction of apoptosis in adenomyosis-derived mesenchymal stem cells by cyclooxygenase-2 inhibitors
article
OA: bronze
CC0
⤵ 30 in-corpus citations
AI-generated summary
Cyclooxygenase-2 inhibitors suppress the migratory and invasive abilities of adenomyosis-derived mesenchymal stem cells while inducing apoptosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (41)
- Adenomyosis—A Result of Disordered Stromal Differentiation via openalex
- Clonogenicity of Human Endometrial Epithelial and Stromal Cells1 via openalex
- Cyclooxygenase-2 Regulates Survival, Migration, and Invasion of Human Endometriotic Cells through Multiple Mechanisms via openalex
- Distribution of cyclooxygenase-2 in eutopic and ectopic endometrium in endometriosis and adenomyosis via openalex
- Endometrial mesenchymal stem cells isolated from the menstrual blood via openalex
- Endometriosis via openalex
- Expression of Cyclooxygenase-2 and Matrix Metalloproteinase-2 in Adenomyosis and Endometrial Polyps and its Correlation With Angiogenesis via openalex
- Gene expression profiles and functional characterization of human immortalized endometriotic epithelial and stromal cells via openalex
- Human endometriosis is associated with plasma cells and overexpression of B lymphocyte stimulator via openalex
- Selective cyclo-oxygenase-2 inhibition induces regression of autologous endometrial grafts by down-regulation of vascular endothelial growth factor-mediated angiogenesis and stimulation of caspase-3-dependent apoptosis via openalex
- Somatic Stem Cells in the Endometrium via openalex
- Suppression of IL-1β-induced COX-2 expression by trichostatin A (TSA) in human endometrial stromal cells via openalex
- W2039506795 via openalex
- W2045714848 via openalex
- W2050339753 via openalex
- W2079224311 via openalex
- W2118462479 via openalex
- W2134812217 via openalex
- W2135630814 via openalex
- W2146710021 via openalex
- W2149348620 via openalex
- W2149825891 via openalex
- W2162491638 via openalex
- W2166030420 via openalex
- W2170621424 via openalex
- W2171224104 via openalex
- W4294216491 via openalex
- W6684281289 via openalex
- W1809740262 via openalex
- W6685236546 via openalex
- W1980776838 via openalex
- W1982032600 via openalex
- W1992207732 via openalex
- W2002963491 via openalex
- W2013614359 via openalex
- W2022884442 via openalex
- W2023821349 via openalex
- W2032712160 via openalex
- W2037331644 via openalex
- W2037865791 via openalex
- W2039274017 via openalex
Cited by (31)
- The interaction between inflammation and estrogen in adenomyosis : from molecular mechanisms to therapeutic strategies 2026
- Ectopic endometrial mesenchymal stem cell-derived exosomal miR-4466 promotes angiogenesis by targeting RUNX1 in adenomyosis 2026
- Proteomic detection of COX-2 pathway-related factors in patients with adenomyosis 2024
- Primary culture of endometrial mesenchymal stem cells derived from ectopic lesions of patients with adenomyosis 2024
- Endometrial cell‑derived exosomes facilitate the development of adenomyosis via the IL‑6/JAK2/STAT3 pathway 2023
- Endometriosis and adenomyosis: common and disparate features 2022
- The Menstrual Endometrium: From Physiology to Future Treatments 2022
- Expressão das proteínas reguladoras da biogênese dos miRNAs em lesões de adenomiose 2022
- Characteristic and Regenerative Potential of Human Endometrial Stem Cells and Progenitors 2021
- Physiopathologie de l’adénomyose : une énigme non résolue 2021
- Endometrial stem/progenitor cells and their roles in immunity, clinical application, and endometriosis 2021
- Increased Migration Ability of Adenomyosis-Derived Endometrial Mesenchymal Stem Cells 2020
- Molecular profile of eutopic and ectopic endometrium in endometriosis 2020
- Adenomyosis: Mechanisms and Pathogenesis 2020
- Uterine Stem Cells and Benign Gynecological Disorders: Role in Pathobiology and Therapeutic Implications 2020
- Immunological changes associated with adenomyosis: a systematic review 2020
- Bioinformatics strategy for the screening of key genes to differentiate adenomyosis from endometriosis (Review) 2019
- Role of angiogenesis in adenomyosis-associated abnormal uterine bleeding and subfertility: a systematic review 2019
- Interaction between BMSCs and EPCs promotes IUA angiogenesis via modulating PI3K/Akt/Cox2 axis. 2018
- Pathogenesis of adenomyosis: an update on molecular mechanisms 2017
- Molecular Characteristics of the Endometrium in Uterine Adenomyosis and Its Biochemical Microenvironment 2017
- Decreased Endometrial Expression of Leukemia Inhibitory Factor Receptor Disrupts the STAT3 Signaling in Adenomyosis During the Implantation Window 2016
- The Pathophysiology of Adenomyosis 2015
- Side Population Cells in Human Adenomyotic Lesions Display Characteristics of Endometrial Stem Cells 2015
- Somatic Stem Cells and Their Dysfunction in Endometriosis 2015
- Potential Mechanisms of an Antiadenomyosis Chinese Herbal Formula Shaoyao‐Gancao Decoction in Primary Cell Culture Model 2014
- Oestrogen‐induced angiogenesis promotes adenomyosis by activating the <scp>S</scp>lug‐<scp>VEGF</scp> axis in endometrial epithelial cells 2014
- Expression of heme oxygenase in the eutopic and ectopic endometrium in patients with adenomyosis 2012
- Pathogenesis and malignant transformation of adenomyosis (Review) 2012
- Mise au point sur l’adénomyose 2012
- Adult stem cells in the endometrium 2010
Source provenance
- europepmc
- last seen: 2026-06-16T06:07:01.518242+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:17:18.915199+00:00
License: CC0
· commercial use OK